Background We assessed the impact of rural trauma team development course (RTTDC) on clinical processes and patient outcomes of motorcycle-accident-related neurological and/or musculoskeletal injuries in selected Ugandan hospitals.

Methods Trial design: Two-arm, parallel, multi-period, cluster-randomized controlled trial.

Participants: Trauma care frontliners, and patients aged 2-80 years at three intervention and three control Ugandan hospitals (1:1 allocation).

Randomization: Hospitals were randomly allocated to intervention or control using permuted block sequences.

Blinding: Patient-participants and outcome assessors were blind to allocation. Intervention arm: 500 trauma care frontliners received RTTDC; patients received standard care.

Control arm: Patients received standard care without RTTDC for staff.

Primary outcomes: Time from accident to admission and from referral to discharge.

Secondary outcomes: 90-day mortality and morbidity related to neurological and/or musculoskeletal injuries.

We followed the CONSORT guidelines for cluster randomized trials.

Results We analyzed 1003 participants (501 intervention, 502 control). The intervention arm had a shorter median prehospital time (1hr; IQR=0·50-2·00) and referral to discharge interval (median 2hrs; IQR=1·25-2·75) vs. [(2hrs; IQR=1·50-4·00) mean difference 1·13hrs, p<0·0001 and (4hrs; IQR=2·50-4·10), mean difference 1·39hrs, p<0·0001 in the control], respectively. The 90-day mortality was more than halved in the intervention (5%, 24/457) vs. (13%, 58/430) in the control arm (p<0·0001). Fewer participants in the intervention group had unfavorable Glasgow Outcome Scale scores (9%, 42/457) vs. (20%, 87/430), p<0·0001. No difference was found in musculoskeletal injury morbidity outcomes (p=0·567).

Interpretation Rural trauma team development training improved organizational time efficiency and clinical outcomes for neurological injuries without negatively impacting musculoskeletal injury morbidity outcomes.

Funding University of Turku Graduate School, Neurocenter-Turku University Hospital, Turku University Hospital Foundation, Center for Health Equity in Surgery and Anesthesia-University of California San Francisco.

Ethical approval Uganda National Council for Science and Technology (Ref: SS 5082).

Trial registration Pan African Clinical Trial Registry (PACTR202308851460352).

Evidence before this study Understaffing and injury-related mortality are highest in low-and middle-income countries (LMICs) where trauma education and training opportunities are scarce.

Observational studies in the US suggest that rural trauma team development training can improve clinician knowledge and reduce pre-hospital intervals.

However, there are no prospective, randomized controlled trials that have assessed the translation of this knowledge and training into clinical practice affecting patient outcomes in LMICs.

Added value of this study In a multi-center, cluster-randomized controlled trial, we investigated the impact of rural trauma team development, training and coordination on pre- and intra-hospital intervals, and outcomes for neurological and musculoskeletal injuries in an African low-resource setting.

Results showed a reduction in prehospital time and all-cause mortality by more than half, without worsening patient-reported trauma morbidity.

Implications of all the available evidence Prognostic level II evidence from this trial supports that locally contextualized, trainee-led rural trauma team development interventional programs are feasible and improve clinical processes and patient outcomes in LMICs.

The authors have declared no competing interest.

Pan African Clinical Trial Registry (PACTR202308851460352).

https://pmc.ncbi.nlm.nih.gov/articles/PMC11109866/

University of Turku Graduate School, Neurocenter-Turku University Hospital, Turku University Hospital Foundation, Center for Health Equity in Surgery and Anesthesia-University of California San Francisco.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval was granted by Uganda National Council for Science and Technology (Ref: SS 5082).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Deidentified participant data and analysis codes that underlie the findings of this study are available within this article as supplemental materials and within an open access data repository.31 Further details can be obtained from the study protocol and trial registry.14https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=25763